Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02908477 | Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer | completed | Phase 3 | 228 | Mayo ClinicOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2025 | clinicaltrials |
| NCT05252884 | Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial | completed | N/A | 258 | Centro de Excelencia en Enfermedades de Cabeza y CuelloOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT04871490 | Improving Detection and Early Action for HPV-positive Oropharynx Cancer(IDEA-HPV) | completed | N/A | 40 | Brigham and Women's HospitalOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT05666193 | On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software | completed | N/A | 30 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Feb 4, 2025 | clinicaltrials |
| NCT05053737 | Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC | completed | Phase 1 | 11 | University of Colorado, DenverOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05349487 | SpeakFree Heat and Moisture Exchanger (HME)(SPEAKFREE) | completed | N/A | 18 | University of MiamiOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03207594 | Improving Evidence-Based Care for Cancer Patients | completed | — | 128 | Medical University of South CarolinaOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT03245489 | Anti-platelet + Pembro for H&N Tumors | completed | Phase 1 | 20 | Medical University of South CarolinaOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT03735745 | Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH) | completed | N/A | 24 | Medical University of South CarolinaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05132205 | Radiofrequency Ablation of Papillary Thyroid Microcarcinoma | completed | N/A | 10 | Johns Hopkins UniversityOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05917067 | Fluorescence Imaging of the Parathyroid Glands of Children(FLUOPATCH) | completed | — | 23 | Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)OTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT01504815 | Adaptive Radiation Treatment for Head and Neck Cancer(ARTFORCE) | completed | Phase 3 | 268 | The Netherlands Cancer InstituteOTHER | 5 | Jan 29, 2025 | clinicaltrials |
| NCT04030130 | Navigation vs Usual Care for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC(NDURE2) | completed | N/A | 176 | Medical University of South CarolinaOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04883645 | Neoadjuvant Imiquimod Immunotherapy for Oral Cancer | completed | Early Phase 1 | 16 | Medical University of South CarolinaOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT02152137 | Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer | completed | Phase 2 | 19 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT05834712 | Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention | completed | N/A | 224 | Sun Yat-sen UniversityOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT06793579 | Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer | completed | — | 21 | Chongqing General HospitalOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06697782 | Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer | completed | Phase 4 | 600 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT05490875 | Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy | completed | — | 60 | Wake Forest University Health SciencesOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT03459729 | Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer | completed | Early Phase 1 | 6 | Medical College of WisconsinOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06778915 | Surgical Strategy for Head and Neck Adenoid Cystic Cancer | completed | — | 309 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 0 | Jan 16, 2025 | clinicaltrials |
| NCT03504488 | CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) | completed | Phase 1 / Phase 2 | 132 | BioAtla, Inc.INDUSTRY | 6 | Jan 15, 2025 | clinicaltrials |
| NCT03518606 | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours(MOVIE) | completed | Phase 1 / Phase 2 | 126 | UNICANCEROTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT01821612 | Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer | completed | Early Phase 1 | 23 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT03715946 | Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | completed | Phase 2 | 40 | Robert L. Ferris, MD, PhDOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma(NEOPBOSCC) | completed | Phase 2 | 68 | Hospital of Stomatology, Wuhan UniversityOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT04673929 | Transoral Robotic Surgery for rECurrent Tumours of the Upper Aerodigestive Tract(RECUT) | completed | — | 278 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04815720 | Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck(KEYNOTE-B84) | completed | Phase 1 / Phase 2 | 49 | Vaccinex Inc.INDUSTRY | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06764420 | Effect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical Trial | completed | N/A | 40 | Ain Shams UniversityOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT04813172 | Enhanced Care Coordination for Head and Neck Cancer Survivors(ECC) | completed | N/A | 250 | University of PittsburghOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06292988 | Predictive Factors for Medullary Thyroid Cancer Aggressiveness(MYELO) | completed | — | 500 | Aristotle University Of ThessalonikiOTHER | 24 | Jan 3, 2025 | clinicaltrials |
| NCT06756763 | Head and Neck Quality of Life | completed | — | 315 | Chang Gung Memorial HospitalOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT05292027 | Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma | completed | N/A | 84 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT02573493 | Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)(APA) | completed | Phase 2 | 96 | Washington University School of MedicineOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04731467 | A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 79 | Famewave Ltd.INDUSTRY | 3 | Dec 27, 2024 | clinicaltrials |
| NCT03997968 | A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 169 | Cyteir Therapeutics, Inc.INDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)(VolATIL) | completed | Phase 2 | 47 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT01945762 | Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer(Caprelsa104) | completed | — | 31 | Genzyme, a Sanofi CompanyINDUSTRY | 8 | Dec 18, 2024 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT02921581 | ReIrradiation With FDG-PET Guided Dose Painting(RIDPAINT) | completed | N/A | 10 | Oslo University HospitalOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT03518554 | A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Jacobio Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 16, 2024 | clinicaltrials |
| NCT04996758 | Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL) | completed | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06730139 | Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment | completed | — | 120 | Ain Shams UniversityOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06726317 | Early Palliative Care For Patients With Oral Cancer in Sri Lanka | completed | N/A | 110 | University of ColomboOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT05796258 | Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer(NTRK) | completed | — | 100 | Regina Elena Cancer InstituteOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06719388 | Exercise Therapy and Jaw-Mobilizing Device for Trismus in Head and Neck Cancer Patients(ET-JMD for Tri) | completed | N/A | 34 | Taipei Medical UniversityOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT05263141 | Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma | completed | N/A | 80 | Sun Yat-sen UniversityOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05760690 | Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola | completed | N/A | 160 | Sun Yat-sen UniversityOTHER | 1 | Dec 3, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Feb 11, 2025source: clinicaltrials